SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Endocyte, Inc. (ECYT)

ECYT RSS Feed
Add ECYT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 10/21/2015 9:12:15 PM - Followers: 33 - Board type: Free - Posts Today: 0


Endocyte (ECYT) NASDAQ
 
The Future Of Drug Targeting  And Predictive Medicine.....
 

We are a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. We use our proprietary technology to create novel small molecule drug conjugates or SMDCs, and companion imaging diagnostics. Our SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone.

We are also developing companion imaging diagnostics for each of our SMDCs that are designed to identify the patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. This combination of an SMDC with its companion imaging diagnostic is designed to personalize the treatment of patients by delivering effective therapy, selectively to diseased cells, in patients most likely to benefit.

Endocyte currently has multiple drugs in human clinical trials. Our lead SMDC, EC145, targets the folate receptor, which is frequently over-expressed in some of the most prevalent, and difficult to treat solid tumor indications, including ovarian, non-small cell lung, breast, colorectal, kidney, endometrial and other cancers. We identify the presence of the folate receptor in cancer patients by using EC20, our proprietary companion imaging diagnostic for EC145.


 

 

[Suppressed Sound Link]






 

 

Pipeline May 2011






 

MASSIVE INSIDER BUYING - 29 Transactions in last year, 11 Transactions since Dec. 13 Results & stock plunge. ALL  BUYS!






 

 

Outstanding Shares  35.74 M

Float 15.72 M

Provided by Morningstar 12/23/11



 

Endocyte Website

 

http://finance.yahoo.com/q/ks?s=ECYT+Key+Statistics



 

  

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ECYT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ECYT News: Mission Therapeutics Appoints Colin Goddard as Chairman 12/05/2016 03:00:00 AM
ECYT News: Endocyte to Present at the IASLC 17th World Conference on Lung Cancer 12/01/2016 08:01:00 AM
ECYT News: Statement of Changes in Beneficial Ownership (4) 11/16/2016 04:02:45 PM
ECYT News: Quarterly Report (10-q) 11/09/2016 05:16:26 PM
ECYT News: Current Report Filing (8-k) 11/09/2016 04:17:28 PM
PostSubject
#341   Actually, E-Shite is what it is, lately. richrichrich 10/21/15 09:12:15 PM
#340   The pharm sector sell off has made this pennystockgenius 10/09/15 12:34:49 PM
#339   Obviously yes. alternatepatel 04/07/15 02:15:59 PM
#338   just below 6$ might be a good entry Mithrandir67 04/07/15 09:57:01 AM
#337   Excellent entry. I'm in quite a bit Bread Man 01/16/15 04:25:11 AM
#336   I jumped in here now near the 52 girlfriend 01/15/15 02:10:57 PM
#335   Agree. I jumped in a few days Bread Man 01/09/15 08:44:37 AM
#334   I consider this stock still as being undervalued. Mithrandir67 01/09/15 08:34:39 AM
#333   yeah, I considered that to be positive as Mithrandir67 10/03/14 11:15:04 AM
#332   On September 27, 2014, Endocyte, Inc. (the "Company") rusty8350 10/03/14 07:40:14 AM
#331   what an amazing decline coming from 9$ just Mithrandir67 10/02/14 10:27:32 AM
#330   yeah...boom! Mithrandir67 09/30/14 10:29:25 AM
#329   BOOM! aristotelisonassis 09/10/14 10:26:16 AM
#328   There was news after hours last night. Rated banker j 09/09/14 11:44:40 AM
#327   +20% on no news?....what did I miss? Mithrandir67 09/09/14 10:53:52 AM
#326   Yeah, each time it goes over $7 I kulnor 09/04/14 03:55:21 AM
#325   yeah, right - but pps has never ever Mithrandir67 09/04/14 02:36:04 AM
#324   Nah, nothing compared to down $15 overnight.... kulnor 09/03/14 07:47:14 PM
#323   ouch!...almost 90cents down in less than two days:-( Mithrandir67 09/03/14 05:20:17 PM
#322   There are no class action suits - only XenaLives 08/29/14 11:58:48 PM
#321   I m there. I am not selling until alternatepatel 08/01/14 11:55:20 AM
#320   Anyone in this? Picked up a few under binks 07/31/14 10:50:57 PM
#319   Earnings beat estimates http://www.wkrb13.com/markets/343358/endocyte-ecyt-post iheartweimers 07/30/14 11:08:57 AM
#318   Endocyte, Inc. [$ECYT] due diligence stocktrademan 07/13/14 11:53:55 AM
#317   Yea so many class action suits, tanking down 1984ISHERE 07/08/14 10:45:02 AM
#316   Somehow I just knew, that the class action richrichrich 06/24/14 09:34:18 PM
#315   images.investorshub.advfn.com/images/uploads/2014/6/23/qxi[bUnbenannt.PNG Leirum 06/23/14 11:17:55 AM
#314   Up 7% so far today. Seems the market MrDanMan 06/23/14 10:48:34 AM
#313   Thanks for this and I agree. Leirum 06/20/14 01:17:47 PM
#312   Pipeline is diverse and have about $5.30/share in MrDanMan 06/20/14 01:09:09 PM
#311   ECYT has more in the Pipeline that the Leirum 06/18/14 03:45:19 AM
#310   I think the time is here to Leirum 06/18/14 03:40:08 AM
#309   No orders accepted right now on my etrade. banker j 06/17/14 04:32:58 PM
#308   No idea but trading here at or near girlfriend 06/17/14 04:30:42 PM
#307   How low do you think this will go? iamiman1 06/17/14 04:22:32 PM
#306   Hit below 5.5 then bounced a little. Stop smallinvestor81 06/17/14 04:22:18 PM
#305   They posted that news right at 4:01pm….sheesh, girlfriend 06/17/14 04:20:49 PM
#304   Why I love options! kittzelle 06/17/14 04:20:03 PM
#303   SA just did a short squeeze story also smallinvestor81 06/17/14 04:15:13 PM
#302   Got it and just got out after hours girlfriend 06/17/14 04:13:59 PM
#301   Merck dropped the drug. $120m deal no longer valid smallinvestor81 06/17/14 04:10:41 PM
#300   Well glad I sold half at least before girlfriend 06/17/14 04:10:00 PM
#299   No doupt! kittzelle 06/17/14 04:09:49 PM
#298   Ouch http://finance.yahoo.com/news/endocyte-regains-worldwide-rights-vintafolide smallinvestor81 06/17/14 04:05:59 PM
#297   Why did I just jump in this..whats going on? kittzelle 06/17/14 03:50:50 PM
#296   Short squeeze happening…..7.73 girlfriend 06/17/14 03:39:23 PM
#295   Maybe Merck buys them out for $22 a share? richrichrich 06/14/14 08:28:11 AM
#294   Endocyte Fails Ovarian Cancer Trial, Now What? Inoviorulez 06/13/14 05:56:55 AM
#293   Merck, Endocyte Withdraw Marketing Applications For Ovarian Cancer justthefacts1 05/21/14 04:54:06 AM
#292   See the new 10Q out at the close? Basically rusty8350 05/12/14 08:02:46 PM
PostSubject